Evidence map›Paper›PMID 33542883›Full record

ReviewCureus2021

Keloid Scars: An Updated Review of Combination Therapies.

Nicholas J Thornton, Benjamin A Garcia, Paige Hoyer, Michael G Wilkerson

Registry-linked trialOpen access · diamondAbstract readReview
In one paragraph

Review in Cureus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06230146 (Efficacy and Safety of Fractional CO2 Laser Combined With Intralesional Insulin, Botulinum Toxin or Triamcinolone Acetonide in the Treatment of Keloid), which is not on this map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06230146 phase1 / phase2unknown statusnot on this mapstarted 2024, after this paper: background citation

Efficacy and Safety of Fractional CO2 Laser Combined With Intralesional Insulin, Botulinum Toxin or Triamcinolone Acetonide in the Treatment of Keloid: A Clinical, Dermoscopic and Immunohistochemical Study.

TypeinterventionalSponsorAssiut UniversityRan2024 to 2026Enrolled45ConditionsKeloidArmsInsulin group, Botulinum toxin group, Triamcinolone acetonide group
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Effectiveness of different non-surgical scar reduction methods in post-operative scars: a systematic review and meta-analysis.Translational breast cancer research : a journal focusing on translational research in breast cancer · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Pharmacotherapy for Keloids and Hypertrophic Scars.International journal of molecular sciences · 2024
    Review
  8. Review
  9. Article
  10. Article
  11. Fractional Carbon Dioxide (CODermatology practical & conceptual · 2022
    Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nicholas J ThorntonDermatology, University of Texas Medical Branch, Galveston, USA.
Benjamin A GarciaDermatology, University of Texas Medical Branch, Galveston, USA.
Paige HoyerDermatology, University of Texas Medical Branch, Galveston, USA.
Michael G WilkersonDermatology, University of Texas Medical Branch, Galveston, USA.
The University of Texas Medical Branch at Galveston · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Keloid scars are a common yet poorly understood complication of wound healing that can cause a diminished quality of life. Currently, there is little agreement amongst the medical community regarding the best treatment modality for keloids. For this reason, we have created an updated review of the most successful combination therapies for keloid scars and compared their efficacy based on rates of recurrence following treatment. Additionally, these combination therapies have been compared with intralesional triamcinolone acetonide corticosteroid (TAC), which is considered the mainstay monotherapy for keloids. All combination therapies included in our review were shown to produce superior outcomes than TAC monotherapy. We have also found that certain combination therapies are known to produce superior results when used in specific anatomic locations. Intralesional TAC plus intralesional cryotherapy appeared to have the most promising results for non-auricular keloids, and the authors suggest considering this as a first-line treatment. Additionally, the use of surgical excision plus compression therapy achieved superior results for auricular keloids and should be considered first-line for keloids in these locations.

Indexed as

combination therapy for keloidscombination therapy for keloid scarscombination treatment for keloidscombination versus monotherapy for keloidskeloidkeloid scarkeloid therapykeloid treatmenttreating keloids

Identifiers

PMID33542883
PMCPMC7847784
OpenAlexW3128464222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.